💰$272k-$302k
📍United States
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company focused on developing complement medicines for autoimmune, neurodegenerative, and ophthalmic disorders. The company’s innovative pipeline includes ANX005, ANX007, and ANX009, targeting the classical complement pathway. Annexon employs a biomarker-driven strategy to enhance the success of its portfolio.
Note: Jobs without salary info will not be shown in the results
Loading data, please wait.
Loading data, please wait.